London Genetics, Diaceutics Developing Software Tools for Biomarker Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – London Genetics and Diaceutics today announced a partnership to develop software tools to provide pharmaceutical companies with access to academic biomarker research groups.

The software will be based on the Diaceutics' Fusion platform, a series of proprietary web applications, and London Genetics' Biomarker Pathway platform.

Terms of the deal were not announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.